ID   SNUCML-02
AC   CVCL_D773
SY   Seoul National University Chronic Myeloid Leukemia-02
DR   Cosmic; 1429043
DR   Wikidata; Q54955310
RX   PubMed=20438801;
CC   Population: Korean.
CC   Doubling time: 24 hours (PubMed=20438801).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=20438801).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 12
//
RX   PubMed=20438801; DOI=10.1016/j.exphem.2010.04.012;
RA   Park J., Kim K.I., Koh Y., Won N.-H., Oh J.M., Lee D.S., Kim B.K.,
RA   Ahn K.-S., Yoon S.-S.;
RT   "Establishment of a new Glivec-resistant chronic myeloid leukemia cell
RT   line, SNUCML-02, using an in vivo model.";
RL   Exp. Hematol. 38:773-781(2010).
//